Copaxone

Teva Faces Delay in $1.2 Billion Kickbacks Case

Teva Gains Trial Postponement for Unique Appeal Strategy in Copaxone Case Against US Government

Anika Sharma

After an enduring three-year legal battle against allegations by the US government, Teva Pharmaceuticals has managed to secure a delay ...